Clinical Diagnostic

Enquiry IconContact Us

Increasing patient awareness and rising demand for high quality care have made it imperative for healthcare providers to develop targeted therapies through specific and sensitive diagnostic tests. Clinical diagnostic tests are used to diagnose a medical condition, provide information about the patient’s health, or monitor a course of disease and assess the patient’s response to treatments. Various techniques of clinical diagnostic testing include blood gas testing, clinical chemistry, immunoassay, coagulation testing, hematology, polymerase chain reaction (PCR), and staining method.

Typically, clinical diagnostic tests involve use of antibody-based techniques for recognizing proteins or disease markers. However, these immunoassays cannot identify all biomarkers in one test and are prone to false-positive and false-negative results. Therefore, there is growing demand for more accurate, efficient, and reliable technologies. This has led to development of alternative testing methods such as LC-MS and GC-MS. However, high initial capital investment and lack of skilled labor is deterring adoption of advance testing devices. Major instruments used in clinical diagnostics include immunoassay analyzer, HPLC system, chemical analyzer, mass spectrometer (MS), LC-MS, and GC-MS. The use of reagents has simplified the testing practice and workflow for personnel in diagnostic laboratories.

New Techniques in Use

Molecular diagnostics is driving growth of the personalized medicine market which involves co-development of drugs/devices and specialized diagnostic tests. The technique is also referred to as companion diagnostic and can be used for toxicity studies, dose selection, monitoring patient response, and patient stratification.

Rapid diagnostic tests are performed at the physician office laboratory (POL), hospitals, health centers and home care. Demand for these tests is increasing rapidly owing to faster and accurate results. Tests have been developed for HbA1c testing, drug abuse, pregnancy testing, micro albumin, creatinine, blood gases, RSV, etc.

Demand for In-vitro diagnostics (IVD) is increasing in emerging markets such as India, China, Brazil, and South Korea. In-vitro diagnostic techniques have transformed the diagnostics industry by eliminating the complex in-vivo testing methods. The IVD techniques include the advance PCR technique, assays and hematology testing, helps diagnose and monitor patient’s health condition using samples of blood, cells or tissues.

Immunoassay diagnostics is expected to be driven by technological advancements such as novel biomarkers, ultrasensitive detection system and assays.

Fragmented Market

The diagnostic landscape, especially in the emerging countries, is highly fragmented and marked by the strong presence of unorganized diagnostic labs. Global players are now building global networks by investing in foreign markets. Moreover, in terms of manufacturers, the market is fragmented in a similar manner with many small players dominating local markets. Owing to the increasing demand for home care, manufacturers and diagnostic laboratories need to work in collaboration to provide quality care at patient convenience.


Increasing healthcare costs is deterring patients from undergoing regular health tests that can be improved with a wider insurance coverage. Inadequate insurance coverage in emerging economies is restricting patients from undergoing expensive health tests, thus fueling the market growth. Moreover, centralization of testing laboratories is projected to drive demand for high volume instrumentation and automation equipment. Demand for IVD tests from Asia Pacific, Latin America and the Middle East markets is also increasing rapidly.

View More

Clinical Diagnostic Published Insights

Coherent Market Insights

Blood Stream Infection Testing Market - Global Forecast to 2026, by Product Type (Instruments, Reagents, and Others), by Technology (Conventional Testing and Non-Conventional Testing), by Test Type (Conventional Blood Culture Tests, PCR Method, Nucleic Acid Testing, Mass Spectroscopy, and Point-of-Care Testing), by End User (Hospitals, Independent Diagnostics Centers, and Others) - Size, Share, Trends, and Forecast 2019 - 2026

Published Date : Jul 2019

Blood stream infection is a condition where any bacterial, fungal or any type of infection is detected in the blood. The condition is evident when the infection enters into the blood stream of any part of the body. The bacteria or organisms that causes the blood infection are determined by using ... View more

Coherent Market Insights

Cholesterol Testing Services Market, By Age Group (Geriatric, Adults, and Pediatric), By Service Provider (Hospitals, Diagnostic Laboratories, Ambulatory Care Centers, and Others) and by Geography - Global Trends and Forecast to 2025

Published Date : Mar 2018

Cholesterol Testing Services Market - Insights Cholesterol is an organic molecule, which is found in all the cells of body. Cholesterol is the precursor to vitamin D and certain hormones. Increase in choleste... View more

Coherent Market Insights

Enteric Disease Testing Market, By Disease Type (E. coli Infection, Salmonellosis, Campylobacteriosis, Rotavirus Infection, Cryptosporidiosis, Norovirus Infection, Cholera, C. difficile, H. pylori, Amebiasis, Shigellosis), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published Date : Aug 2020

Enteric diseases are intestinal infections caused by a variety of bacteria, viruses and parasites when they enter the body through the mouth or intestinal systems such as salmonella, shigella, giardia lamblia, campylobacter, cryptosporidium and vibrio cholerae causing... View more

Coherent Market Insights

Hemoglobin A1c Testing Devices Market, By Test Type (Laboratory Testing Devices, Point-of-care Testing Devices), By Technology (Ion-Exchange HPLC, Immunoassay, Boronate Affinity Chromatography, Direct Enzymatic Assay, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published Date : May 2020

Hemoglobin A1c test is a common blood test performed for diagnosis and monitoring of type 1 and type 2 diabetes. A1c test results reflect the average blood sugar levels of an individual for the past two to three months. Hemoglobin (Hb) is a protein that links with sug... View more

Coherent Market Insights

Preimplantation Genetic Diagnosis Market, By Type (Chromosomal Abnormalities, Aneuploidy, X-linked diseases, Single gene disorders, HLA Typing, Gender Selection, Others (for disability, adult onset disease)), By End User (Diagnostic Laboratories, Hospitals, Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published Date : Oct 2020

Preimplantation genetic diagnosis is used to test aneuploidy in the cases of low prognosis in patients opting for in vitro fertilization. It is also instrumental in detection of hereditary single gene disorders, X linked diseases and recently, also for diagnosis of la... View more

Coherent Market Insights

Non-invasive Prenatal Testing (NIPT) Market, By Test Type (Panel 1 Test, Panel 2 Test, Panel 3 Test), By End User (Hospitals, Diagnostic Laboratories, Maternity Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published Date : Oct 2020

Non-invasive prenatal testing (NIPT) is an innovative way of screening pregnancies for fetal chromosomal aneuploidies by analyzing fetal cell-free DNA circulating in maternal blood. It involves the testing for particular diseases or birth defects in a fetus or embryo ... View more

Subscribe Newsletter

Kindly subscribe for our latest news & articles.